| Chantel Eberle, LIMHP | |
|
1309 Harlan Dr Ste 102, Bellevue, NE 68005-6604 | |
| (402) 215-9998 | |
| (402) 991-7631 |
| Full Name | Chantel Eberle |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 1309 Harlan Dr Ste 102, Bellevue, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881112506 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | 5063 (Nebraska) | Secondary |
| 101YP2500X | Counselor - Professional | 2001 (Nebraska) | Secondary |
| 101YM0800X | Counselor - Mental Health | 10724 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Chantel Eberle, LIMHP 3980 S 150th Plz, Omaha, NE 68144-5538 Ph: (402) 215-9998 | Chantel Eberle, LIMHP 1309 Harlan Dr Ste 102, Bellevue, NE 68005-6604 Ph: (402) 215-9998 |
News Archive
Stem cell researchers at UCLA have discovered that three types of cells derived from human embryonic stem cells and induced pluripotent stem cells are similar to each other, but are much more developmentally immature than previously thought when compared to those same cell types taken directly from human tissue.
Adding to what is known about the growing crisis of suicide among American teens, a team led by researchers at the McSilver Institute for Poverty Policy and Research at New York University have uncovered several troubling trends during the period of 1991-2017, among Black high school students in particular.
StemCyte, Inc. concluded an exclusive license and commercialization agreement with Academia Sinica, the National Laboratory of Taiwan, for certain proprietary methods and Intellectual Property (IP) related to the treatment of Chronic Stroke with stem cells.
BioDelivery Sciences International, Inc. announced the approval by the U.S. Food and Drug Administration of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant.
› Verified 5 days ago
Katherine Kimmerling, LIMHP, LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 730 Fort Crook Rd N, Bellevue, NE 68005 Phone: 402-292-9105 Fax: 402-292-0342 | |
Mrs. Alyson Nichole Carter, LIMHP, PLADC,CPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 608 W 29th Ave, Bellevue, NE 68005 Phone: 419-203-3620 | |
Veronica Villa, PLADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1103 Galvin Rd S Ste L 1/2, Bellevue, NE 68005 Phone: 402-213-1655 | |
Jessica Fuller, PLMHP Counselor Medicare: Medicare Enrolled Practice Location: 11515 S 39th St, Bellevue, NE 68123 Phone: 402-292-9105 Fax: 402-292-0342 | |
Nandi Nzingha Naomi Thomas, PLADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 112 E Mission Ave, Bellevue, NE 68005 Phone: 402-257-1122 | |
Catherine Jo Howard, LMHP LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 1309 Harlan Dr Ste 102, Bellevue, NE 68005 Phone: 402-850-0151 | |
Nina Wilson, LMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 1406 Fort Crook Rd S, 401, Bellevue, NE 68005 Phone: 402-661-9102 |